Related case:
CAS 2012/A/2960 WADA vs Angela Covert & FEI
January 31, 2014
Fact
The International Equestrian Federation (FEI) alleges Angela Covert (the athlete) for a violation of the Anti-Doping Rules. Angela Covert (the "Athlete") participated at the CSI4*-W, Spruce Meadows AB in Calgary, Canada from 30 June to 3 July 2011 (the "Event"), in the discipline of Jumping. On 30 June 2011, the Athlete was selected for in-competition testing. Analysis of urine sample revealed the presence of Methylhexaneamine (Dimethylphentylamine) which is a Prohibited Substance according to the 2011 Prohibited List of the World Anti-Doping Agency ("WADA") and is considered a "Specified Substance".
History
On 25 August 2011, the Athlete requested for the B-Sample
analysis to be performed in a different laboratory than the A-Sample analysis. She argues that because of the use of a nasal spray (Euvanol Spray), due to a fractured nose to stop the bleeding. The prohibited substance was not listed as a ingredient, but it contained geranium oil which has a small percentage of the prohibited substance. An expert stated that this amount is consistent with the results of the sample test. She didn't want to enhance her performance. Because Methylhexaneamine was a Specified Substance, Article 10.4 of the ADRHA had to be applied and since it was the Athlete's first violation, only a reprimand and no period of Ineligibility should be imposed on her.
Decision
1. The Athlete shall be formally reprimanded.
2. The Athlete is fined CHF 500.
3. According to Article 168.4 of the GRs, the present Decision is
effective from the day of written notification to the persons and
bodies concerned.
Appeal
In accordance with Article 12 of the ADRHA, the Athlete and the
FEI may appeal against this decision by lodging an appeal with the
Court of Arbitration for Sport within 30 days of receipt hereof.
Costs
Each Party shall bear its own legal costs of the legal procedure.
